Salesforce.com is OVERWEIGHT and 4 Stock Analyses to Note
Valero Energy Corp. (NYSE:VLO): According to Dahlman Rose, Valero has continued with its capex budget of $2 billion to $2.5 billion for next year, allowing it to keep its cash return acceleration during its upgrade cycle next year. Shares have a Buy rating.
Abercrombie & Fitch Co. (NYSE:ANF): Yesterday, CNBC reported that Abercrombie & Fitch chose to hire Goldman Sachs (NYSE:GS), which causes Nomura to believe that the retailer has no intentions of taking any noticeable action. The firm keeps a Neutral rating on the stock.
Celgene Corporation (NASDAQ:CELG) continues to be a leading large cap biotech pick after yesterday’s investor meetings, according to Cowen. This is due to the company’s Revlimid franchise, management confidence in gaining its guidance, along with a strong pipeline. Shares have an Outperform rating.
Polypore International Inc. (NYSE:PPO): According to Needham, the company had an analyst event that was packed with information where it took the time to clarify the Celgard brand’s advantages with efficiency over the competition. The firm predicts an improvement in volumes in the near future, and the firm keeps its Strong Buy rating but reduced the price target to reflect the company’s revised guidance that was issued on Tuesday
Salesforce.com (NYSE:CRM) shares are believed by Morgan Stanley to continue to move higher due to the recent hires that are increasing productivity, large deal acceleration, newer offerings traction, and easier comps, among other reasons. Shares are given an Overweight rating and a $180 price target.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>